Proteomic analysis of β-catenin activation in mouse liver by DIGE analysis identifies glucose metabolism as a new target of the Wnt pathway

Proteomics

Volumn 9, Issue 15, 2009, Pages 3889-3900

  Chafey, Philippe ^a   Finzi, Laetitia ^a   Boisgard, Raphael ^b   Caüzac, Michèle ^a   Clary, Guillem ^a   Broussard, Cédric ^a   Pégorier, Jean Paul ^a   Guillonneau, François ^a   Mayeux, Patrick ^a   Camoin, Luc ^b   Tavitian, Bertrand ^b   Colnot, Sabine ^a   Perret, Christine ^a  

^a INSTITUT COCHIN   (France)

^b SERVICE HOSPITALIER FRÉDÉRIC JOLIOT   (France)

Author keywords

Adenomatous polyposis coli; DIGE; Mouse liver; catenin

Indexed keywords

AMMONIA; BETA CATENIN; FLUORODEOXYGLUCOSE F 18; FRUCTOSE BISPHOSPHATASE; GLUCOSE; GLUTAMATE AMMONIA LIGASE; LACTATE DEHYDROGENASE; ORNITHINE OXOACID AMINOTRANSFERASE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE ALPHA; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE BETA; UNCLASSIFIED DRUG; WNT PROTEIN;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; GLUCOSE METABOLISM; GLYCOLYSIS; LIVER METABOLISM; MALE; MASS SPECTROMETRY; MOUSE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; PROTEOMICS; SIGNAL TRANSDUCTION; TWO DIMENSIONAL DIFFERENTIAL GEL ELECTROPHORESIS; TWO DIMENSIONAL ELECTROPHORESIS;

MUS;

EID: 68549117276     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200800609     Document Type: Article

References (25)

1. Clevers, H., Wnt/beta-catenin signaling in development and disease. Cell 2006, 127, 469-480.
2. de La Coste, A., Romagnolo, B., Billuart, P., Renard, C. A. et al., Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc. Natl. Acad. Sci. USA 1998, 95, 8847-8851.
3. Laurent-Puig, P., Zucman-Rossi, J., Genetics of hepatocellular tumors. Oncogene 2006, 25, 3778-3786.
4. Cadoret, A., Ovejero, C., Saadi-Kheddouci, S., Souil, E. et al., Hepatomegaly in transgenic mice expressing an oncogenic form of beta-catenin. Cancer Res. 2001, 61, 3245-3249.
5. Colnot, S., Decaens, T., Niwa-Kawakita, M., Godard, C. et al., Liver-targeted disruption of Apc in mice activates betacatenin signaling and leads to hepatocellular carcinomas. Proc. Natl. Acad. Sci. USA 2004, 101, 17216-17221.
6. Decaens, T., Godard, C., de Reynies, A., Rickman, D. S. et al., Stabilization of beta-catenin affects mouse embryonic liver growth and hepatoblast fate. Hepatology 2008, 47, 247-258.
7. Apte, U., Zeng, G., Thompson, M. D., Muller, P. et al., Betacatenin is critical for early postnatal liver growth. Am. J. Physiol. Gastrointest. Liver Physiol. 2007, 292, G1578-G1585.
8. Sekine, S., Gutierrez, P. J., Lan, B. Y., Feng, S. et al., Liver-specific loss of beta-catenin results in delayed hepatocyte proliferation after partial hepatectomy. Hepatology 2007, 45, 361-368.
9. Tan, X., Behari, J., Cieply, B., Michalopoulos, G. K. et al., Conditional deletion of beta-catenin reveals its role in liver growth and regeneration. Gastroenterology 2006, 131, 1561-1572.
10. Benhamouche, S., Decaens, T., Godard, C., Chambrey, R. et al., Apc tumor suppressor gene is the "zonation-keeper" of mouse liver. Dev. Cell. 2006, 10, 759-770.
11. Jungermann, K., Kietzmann, T., Zonation of parenchymal and nonparenchymal metabolism in liver. Annu. Rev. Nutr. 1996, 16, 179-203.
12. Kroemer, G., Pouyssegur, J., Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell 2008, 13, 472-482.
13. Bergmeyer, H. U., Methods in Enzymatic Analysis. 2nd Edn. (Translated from the 3rd German Edn.) Academic Press, New York 1974.
14. Maroy, R., Boisgard, R., Comtat, C., Frouin, V. et al., Segmentation of rodent whole-body dynamic PET images: an unsupervised method based on voxel dynamics. IEEE Trans. Med. Imaging 2008, 27, 342-354.
15. Audard, V., Grimber, G., Elie, C., Radenen, B. et al., Cholestasis is a marker for hepatocellular carcinomas displaying beta-catenin mutations. J. Pathol. 2007, 212, 345-352.
16. Gatenby, R. A., Gillies, R. J., Why do cancers have high aerobic glycolysis? Nat. Rev. Cancer 2004, 4, 891-899.
17. Warburg, O., On the origin of cancer cells. Science 1956, 123, 309-314.
18. Shaw, R. J., Glucose metabolism and cancer. Curr. Opin. Cell. Biol. 2006, 18, 598-608.
19. Khan, M. A., Combs, C. S., Brunt, E. M., Lowe, V. J. et al., Positron emission tomography scanning in the evaluation of hepatocellular carcinoma. J. Hepatol. 2000, 32, 792-797.
20. Haberkorn, U., Hoffend, J., Schmidt, K., Altmann, A. et al., Changes in glucose metabolism and gene expression after transfer of anti-angiogenic genes in rat hepatoma. Eur. J. Nucl. Med. Mol. Imaging 2007, 34, 2011-2023.
21. Lin, W. Y., Tsai, S. C., Hung, G. U., Value of delayed 18F-FDG-PET imaging in the detection of hepatocellular carcinoma. Nucl. Med. Commun. 2005, 26, 315-321.
22. Trojan, J., Schroeder, O., Raedle, J., Baum, R. P. et al., Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma. Am. J. Gastroenterol. 1999, 94, 3314-3319.
23. Paudyal, B., Paudyal, P., Oriuchi, N., Tsushima, Y. et al., Clinical implication of glucose transport and metabolism evaluated by 18F-FDG PET in hepatocellular carcinoma. Int. J. Oncol. 2008, 33, 1047-1054.
24. Strathmann, J., Paal, K., Ittrich, C., Krause, E. et al., Proteome analysis of chemically induced mouse liver tumors with different genotype. Proteomics 2007, 7, 3318-3331.
25. Blanc, J. F., Lalanne, C., Plomion, C., Schmitter, J. M. et al., Proteomic analysis of differentially expressed proteins in hepatocellular carcinoma developed in patients with chronic viral hepatitis C. Proteomics 2005, 5, 3778-3789.